NEOVACS Alternatives & Competitors
12 companies similar to NEOVACS — Nous développons les thérapies de demain et investissons dans des sociétés innov...
Companies similar to NEOVACS
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
AnaptysBio
Transforming patient health by delivering innovative immunology therapeutics.
Novelogics Biotechnology Inc.
Pre-clinical stage biotech company developing an antibody immunotherapy drug for cancer us...
Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...
Rival Readout
Competing with NEOVACS? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
MabGenesis Inc.
Discovery of innovative therapeutic antibodies for human and animal health
United Biomedical, Inc. (UBI)
Pioneering the future of healthcare with innovative immunotherapeutics and vaccines for ch...
Evelo Biosciences
Clinical stage biotech company developing a new modality of oral biologics that act on cel...
Precision Biologics, Inc.
Precision Biologics, Inc. has a cancer immunotherapy platform with 2 unique clinical stage...
ImmunGene
Innovation in antibody-cytokine fusion technology and monoclonal antibody-based therapies...
Cantargia AB
A Swedish listed biotechnology company
About NEOVACS
**NEOVACS** NEOVACS is a French Biotechnology company founded in 1993. Their mission is to develop therapeutic vaccines for the treatment of autoimmune and inflammatory diseases. Additionally, they invest in innovative companies within the Biotech and Medtech industries.
biotechnology research and development, drug development, investing in biotech and medtech companies
patients with lupus and allergies, biotech and medtech companies
Therapeutic Vaccines, Autoimmune Diseases, Inflammatory Diseases, Immunotherapy, Medtech, AIDS Treatment, Cancer Treatment, Polyclonal Antibody Response, Immunologist, Viral Proteins, Monoclonal Antibodies, Cytokine-related Diseases, Allergic Diseases
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around NEOVACS: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at NEOVACS on 7 Jun 2025. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.